Jhaveri Nirav S. — SEC insider filings

SEC reporting owner CIK 2011481. 6 insider filings on record with FilingPulse; latest filed 2026-10-05.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-02-14 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Opus Genetics, Inc. (IRD)Chief Financial Officer41 leg · 10,000 sh · $21,000—5
Longeveron Inc. (LGVN)Chief Financial Officer2——2

Insider filings — Jhaveri Nirav S.

FiledFormIssuerReported transactionsSource
2026-10-054Longeveron Inc. (LGVN)Tax withholding (F): 742 @ $2.59EDGAR
2026-08-254Longeveron Inc. (LGVN)Grant/award (A): 300,000 @ $0EDGAR
2025-03-174Opus Genetics, Inc. (IRD)Grant/award (A): 52,500 @ $0 · Grant/award (A): 52,500 (derivative) @ $0EDGAR
2025-02-184Opus Genetics, Inc. (IRD)Tax withholding (F): 8,207 @ $1.15EDGAR
2024-03-254Ocuphire Pharma, Inc. (OCUP)Purchase (P): 10,000 @ $2.10EDGAR
2024-02-144Ocuphire Pharma, Inc. (OCUP)Grant/award (A): 140,000 @ $0 · Grant/award (A): 210,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2011481 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs